Calumet Specialty Products Partners LPCLMT:NSQ

28.13
0.58 / 2.11%
149.26k
14.34 %
0.8751
Latest price in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 28 2015 16:04 BST.

Summary

As of last trade Calumet Specialty Products Partners LP (CLMT:NSQ) traded at 28.13, 15.32 % below its 52-week high of 33.22, set on Jul 28, 2014.

52-week range
Today
18.66
Dec 16 2014
33.22
Jul 28 2014
Markit short selling activity
Low
Medium
High
Open27.70
Day high28.19
Day low27.26
Bid28.14
Offer28.20
Previous close27.55
Average volume327.96k
Shares outstanding75.76m
Free float58.61m
P/E (TTM)--
Market cap2.09bn USD
EPS (TTM)-0.7759 USD
Annual div (IAD)2.74 USD
Annual div yield (IAD)9.95%
Div ex-dateMay 01 2015
Div pay-dateMay 15 2015
Next div ex-dateJul 31 2015
Next div pay-dateAug 14 2015
Data delayed at least 15 minutes, as of Jul 28 2015 16:04 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Calumet Specialty Products Partners LP+3.57 %+6.35 %+7.74 %-14.34 %+48.05 %
S&P 500 INDEX-2.43 %-1.61 %+1.88 %+4.48 %+86.93 %
Data delayed at least 15 minutes, as of Jul 28 2015 16:04 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.